Alzheimer’s risk gene APOE4 may have a reversible weakness

Mount Sinai researchers have identified how the APOE4 gene damages brain blood vessels, potentially contributing to Alzheimer's disease. The study suggests that this vascular damage might be reversible, opening new avenues for treatment development.
Why it matters
Understanding the mechanism of APOE4-related vascular damage provides a new target for therapeutic interventions in Alzheimer's research.
Mount Sinai researchers have uncovered new details about how APOE4 , the strongest known genetic risk factor for Alzheimer's disease, may contribute to brain damage. Two studies published in Cell and Cell Stem Cell show that the gene can damage blood vessels in the brain and encourage the accumulation of abnormal proteins associated with neurodegenerative disease. The findings point to disease processes that may be reversible and also highlight a new human brain tissue platform derived from stem cells that could speed up the search for treatments.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in